Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B

Journal of Viral Hepatitis

Volumn 15, Issue 11, 2008, Pages 817-826

  Vassilopoulos, D ^b   Rapti, I ^a   Nikolaou, M ^b   Hadziyannis, E ^b   Hadziyannis, S J ^a  

^a HENRY DUNANT HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Acute hepatitis B; Cellular immunity; Chronic hepatitis B; Hepatitis B surface antigen; Hepatitis B virus; Interferon

Indexed keywords

GAMMA INTERFERON; HEPATITIS E ANTIGEN; SYNTHETIC PEPTIDE; VIRUS PROTEIN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; FEMALE; HEPATITIS B ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS;

EID: 54849442483     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2008.00996.x     Document Type: Article

References (26)

1. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995 13 : 29 60.
2. Bertoletti A, Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology 2003 38 : 4 13.
3. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005 5 : 215 229.
4. Hadziyannis SJ. Hepatitis B e antigen negative chronic hepatitis B: from clinical recognition to pathogenesis and treatment. Viral Hepat Rev 1995 1 : 7 36.
5. Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 2006 43 : S173 S181.
6. de Franchis R, Hadengue A, Lau G et al. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol 2003 39 (Suppl. 1 S3 S25.
7. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007 45 : 507 539.
8. Hadziyannis SJ, Vassilopoulos D. Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 2001 34 : 617 624.
9. Chu CJ, Keeffe EB, Han SH et al. Prevalence of HBV precore/core promoter variants in the United States. Hepatology 2003 38 : 619 628.
10. Funk ML, Rosenberg DM, Lok AS. World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepat 2002 9 : 52 61.
11. Hadziyannis SJ, Vassilopoulos D. Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection. Antiviral Res 2001 52 : 91 98.
12. Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995 22 : 696 699.
13. Kimura K, Ando K, Tomita E et al. Elevated intracellular IFN-gamma levels in circulating CD8+ lymphocytes in patients with fulminant hepatitis. J Hepatol 1999 31 : 579 583.
14. Mizukoshi E, Sidney J, Livingston B et al. Cellular immune responses to the hepatitis B virus polymerase. J Immunol 2004 173 : 5863 5871.
15. Chu CM, Liaw YF, Yang CY, Sheen IS. Peripheral T-cell subsets in chronic type B hepatitis: correlation with biochemical and histological activities and hepatitis B e antigen/antibody status. Cell Immunol 1984 86 : 562 566.
16. Thomas HC, Brown D, Labrooy J, Epstein O. T cell subsets in autoimmune and HBV-induced chronic liver disease, HBs antigen carriers with normal histology and primary biliary cirrhosis: a review of the abnormalities and the effects of treatment. J Clin Immunol 1982 2 : 57S 60S.
17. Chu CM, Liaw YF. Peripheral T-cell subsets in asymptomatic hepatitis B-virus carriers. Cell Immunol 1986 98 : 533 537.
18. Diepolder HM, Jung MC, Wierenga E et al. Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro. J Virol 1996 70 : 7540 7548.
19. Ferrari C, Penna A, Bertoletti A et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 1990 145 : 3442 3449.
20. Jung MC, Spengler U, Schraut W et al. Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J Hepatol 1991 13 : 310 317.
21. Jung MC, Diepolder HM, Spengler U et al. Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol 1995 69 : 3358 3368.
22. Jung MC, Hartmann B, Gerlach JT et al. Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection. Virology 1999 261 : 165 172.
23. Lohr HF, Weber W, Schlaak J, Goergen B, Meyer zBK, Gerken G. Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants. Hepatology 1995 22 : 61 68.
24. Marinos G, Torre F, Chokshi S et al. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. Hepatology 1995 22 : 1040 1049.
25. Hyodo N, Tajimi M, Ugajin T, Nakamura I, Imawari M. Frequencies of interferon-gamma and interleukin-10 secreting cells in peripheral blood mononuclear cells and liver infiltrating lymphocytes in chronic hepatitis B virus infection. Hepatol Res 2003 27 : 109 116.
26. Maini MK, Boni C, Lee CK et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000 191 : 1269 1280.